Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study

Abstract

In optimally treated CAD patients influenza vaccination improves the clinical course of CAD and reduces the frequency of coronary ischaemic events. Large-scale studies are warranted to evaluate the effect of influenza vaccination on cardiovascular mortality. (ClinicalTrials.gov: NCT 00371098).